Tech Company Financing Transactions

Allecra Therapeutics Funding Round

Delos Capital, Edmond de Rothschild Investment Partners and EMBL Ventures participated in a $24.8 million Series B funding round for Allecra Therapeutics. The round was announced by the company on 6/16/2016.

Transaction Overview

Company Name
Allecra Therapeutics
Announced On
6/16/2016
Transaction Type
Venture Equity
Amount
$24,779,700
Round
Series B
Investors

Delos Capital (Lead Investor) (Henry Chen)

Edmond de Rothschild Investment Partners

EMBL Ventures

Forbion Capital Partners (Holger Reithinger)

private investors (Nicholas Benedic)

Proceeds Purpose
The proceeds will fund Phase 2 development of AAI202, Allecra's proprietary, novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Im Kränzliacker 9
Weil am Rhein, 79576
Germany
Phone
+41 79 592 2005
Website
www.allecra.com
Email Address
Not Recorded
Overview
Allecra Therapeutics, a clinical stage biopharmaceutical company Allecra was established in 2013 and is focused on the development of novel treatments to combat multi drug-resistant bacterial infections.
Profile
Allecra Therapeutics LinkedIn Company Profile
Social Media
Allecra Therapeutics Company Twitter Account
Company News
Allecra Therapeutics News
Facebook
Allecra Therapeutics on Facebook
YouTube
Allecra Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Bert Willink
  Bert Willink LinkedIn Profile  Bert Willink Twitter Account  Bert Willink News  Bert Willink on Facebook
Chief Executive Officer
Klaus Wilgenbus
  Klaus Wilgenbus LinkedIn Profile  Klaus Wilgenbus Twitter Account  Klaus Wilgenbus News  Klaus Wilgenbus on Facebook
Chief Financial Officer
Andrew Smith
  Andrew Smith LinkedIn Profile  Andrew Smith Twitter Account  Andrew Smith News  Andrew Smith on Facebook
Chief Financial Officer
Brice Suire
  Brice Suire LinkedIn Profile  Brice Suire Twitter Account  Brice Suire News  Brice Suire on Facebook
VP - Bus. Development
Mathias Knecht
  Mathias Knecht LinkedIn Profile  Mathias Knecht Twitter Account  Mathias Knecht News  Mathias Knecht on Facebook
VP - Regulatory Affairs
Omar Lalhou
  Omar Lalhou LinkedIn Profile  Omar Lalhou Twitter Account  Omar Lalhou News  Omar Lalhou on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/16/2016: Muzooka venture capital transaction
Next: 6/16/2016: Yewno venture capital transaction

 

Share this article

 

News on VC Transactions

We record tech company VC transactions. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.